Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
- U-BIOPRED (Unbiased Biomarkers for the Prediction of Respiratory Disease outcome) Study Group and the BIOAIR (Longitudinal Assessment of Clinical Course and Biomarkers in Severe Chronic Airway Disease) Consortium
- KTH Royal Institute of Technology
- Karolinska Institutet
- Knowles Consulting, Stevenage Bioscience Catalyst, Stevenage, United Kingdom;
- Science for Life Laboratory
- Medical University of Łódź
- European Institute of Systems Biology and Medicine, 69390 Lyon, France
- University of Bergen
- University of Modena and Reggio Emilia
- University of Catania
- AP-HM Assistance Publique - Hôpitaux de Marseille
- University of Copenhagen
- Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK
- National and Kapodistrian University of Athens
- University of Bern
- National Research Council of Italy
- Semmelweis University
- University Hospital Southampton NHS Foundation Trust
- Imperial College London
- Ghent University
- Fraunhofer Institute for Toxicology and Experimental Medicine
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland
- AstraZeneca
- University of Ferrara
- Kiel University
- Umeå University
- University of Nottingham
- University of Crete
- GlaxoSmithKline
- Knowles Consulting
- Karolinska University Hospital
- European Institute for Systems Biology and Medicine
- University of Amsterdam
- University of Manchester
- Bern University Hospital ‘Inselspital’
- Consiglio Nazionale delle Ricerche
- 1st Department of Cardiology, Interventional Electrocardiology and Hypertension, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland
- AstraZeneca Sweden
Research output: Contribution to journal › Article › Academic › peer-review
17
Downloads
(Pure)